Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 111 articles:
HTML format
Text format



Single Articles


    May 2019
  1. OTTO CM
    Heartbeat: Primary care delays in heart failure diagnosis.
    Heart. 2019;105:661-662.
    PubMed     Text format    


    April 2019
  2. SALAH K, Stienen S, Pinto YM, Eurlings LW, et al
    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314173. doi: 10.1136/heartjnl-2018-314173.
    PubMed     Text format     Abstract available


  3. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    PubMed     Text format     Abstract available


    March 2019
  4. CHRISTIANSEN MN, Kober L, Torp-Pedersen C, Smith JG, et al
    Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.
    Heart. 2019 Mar 25. pii: heartjnl-2018-314552. doi: 10.1136/heartjnl-2018-314552
    PubMed     Text format     Abstract available


  5. ANDERSON LJ, Squire IB, Cowie MR
    Global lessons from deaths from heart failure in UK hospitals.
    Heart. 2019 Mar 2. pii: heartjnl-2018-314641. doi: 10.1136/heartjnl-2018-314641.
    PubMed     Text format    


    February 2019
  6. FROHLICH H, Rosenfeld N, Tager T, Goode K, et al
    Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Heart. 2019 Feb 21. pii: heartjnl-2018-314256. doi: 10.1136/heartjnl-2018-314256
    PubMed     Text format     Abstract available


  7. BURDEN AF, Timpson N
    Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
    Heart. 2019 Feb 6. pii: heartjnl-2018-314467. doi: 10.1136/heartjnl-2018-314467.
    PubMed     Text format    


    January 2019
  8. EZEKOWITZ JA
    Creating order out of chaos: quality of care in heart failure.
    Heart. 2019 Jan 31. pii: heartjnl-2018-314526. doi: 10.1136/heartjnl-2018-314526
    PubMed     Text format    


  9. AGARWAL A, Bahiru E, Yoo SGK, Berendsen MA, et al
    Hospital-based quality improvement interventions for patients with heart failure: a systematic review.
    Heart. 2019 Jan 30. pii: heartjnl-2018-314129. doi: 10.1136/heartjnl-2018-314129
    PubMed     Text format     Abstract available


  10. PINHO-GOMES AC, Rahimi K
    Management of blood pressure in heart failure.
    Heart. 2019 Jan 23. pii: heartjnl-2018-314438. doi: 10.1136/heartjnl-2018-314438
    PubMed     Text format     Abstract available


  11. TAN ESJ, Tay WT, Teng TK, Sim D, et al
    Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314077. doi: 10.1136/heartjnl-2018-314077
    PubMed     Text format     Abstract available


  12. TAYLOR CJ
    Diagnosing heart failure: challenges in primary care.
    Heart. 2019 Jan 15. pii: heartjnl-2018-314396. doi: 10.1136/heartjnl-2018-314396
    PubMed     Text format    


  13. OTTO CM
    Heartbeat: heart failure induced by cancer therapy.
    Heart. 2019;105:1-3.
    PubMed     Text format    


    December 2018
  14. HAYHOE B, Kim D, Aylin PP, Majeed FA, et al
    Adherence to guidelines in management of symptoms suggestive of heart failure in primary care.
    Heart. 2018 Dec 4. pii: heartjnl-2018-313971. doi: 10.1136/heartjnl-2018-313971.
    PubMed     Text format     Abstract available


  15. DEFARIA YEH D, Stefanescu Schmidt AC, Eisman AS, Serfas JD, et al
    Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease.
    Heart. 2018;104:2044-2050.
    PubMed     Text format     Abstract available


    October 2018
  16. AL RIFAI M, Blaha MJ, Rahman F, Ehrman JK, et al
    Inverse association of pulse pressure augmentation during exercise with heart failure and death.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313736. doi: 10.1136/heartjnl-2018-313736
    PubMed     Text format     Abstract available


  17. MILANI GP, Bianchetti MG, Lava SA
    Measurement of sodium in heart failure.
    Heart. 2018;104:1724.
    PubMed     Text format    


  18. BUBER J, Valente AM
    Predicting survival in adults with congenital heart disease: what are the odds?
    Heart. 2018;104:1643-1644.
    PubMed     Text format    


    September 2018
  19. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Text format     Abstract available


  20. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Text format     Abstract available


  21. DIBBEN GO, Dalal HM, Taylor RS, Doherty P, et al
    Cardiac rehabilitation and physical activity: systematic review and meta-analysis.
    Heart. 2018;104:1394-1402.
    PubMed     Text format     Abstract available


  22. KRUPICKOVA S, Morgan GJ, Cheang MH, Rigby ML, et al
    Symptomatic partial and transitional atrioventricular septal defect repaired in infancy.
    Heart. 2018;104:1411-1416.
    PubMed     Text format     Abstract available


    August 2018
  23. SZE S, Pellicori P, Zhang J, Clark AL, et al
    Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313312. doi: 10.1136/heartjnl-2018-313312
    PubMed     Text format     Abstract available


  24. WOLFSON AM, Fong M, Grazette L, Rahman JE, et al
    Chronic heart failure management and remote haemodynamic monitoring.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313397. doi: 10.1136/heartjnl-2018-313397
    PubMed     Text format     Abstract available


  25. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Text format     Abstract available


  26. SULTAN I, Cardounel A, Abdelkarim I, Kilic A, et al
    Right ventricle to pulmonary artery coupling in patients undergoing transcatheter aortic valve implantation.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313385. doi: 10.1136/heartjnl-2018-313385.
    PubMed     Text format     Abstract available


  27. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    PubMed     Text format     Abstract available


  28. CHOUSOU PA, Pugh PJ
    How to deliver optimal cardiac resynchronisation therapy.
    Heart. 2018;104:1300-1307.
    PubMed     Text format    


    July 2018
  29. PRASAD SB, Holland DJ, Atherton JJ
    Diastolic stress echocardiography: from basic principles to clinical applications.
    Heart. 2018 Jul 20. pii: heartjnl-2017-312323. doi: 10.1136/heartjnl-2017-312323
    PubMed     Text format     Abstract available


  30. LYON AR
    Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.
    Heart. 2018 Jul 4. pii: heartjnl-2018-313493. doi: 10.1136/heartjnl-2018-313493.
    PubMed     Text format    


  31. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed     Text format    


  32. NANCHEN D
    Resting heart rate: what is normal?
    Heart. 2018;104:1048-1049.
    PubMed     Text format    


  33. JARVIE JL, Metz TD, Davis MB, Ehrig JC, et al
    Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.
    Heart. 2018;104:1187-1194.
    PubMed     Text format     Abstract available


    June 2018
  34. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed     Text format    


  35. ZHU K, Knuiman M, Divitini M, Murray K, et al
    High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Heart. 2018;104:895-903.
    PubMed     Text format     Abstract available


  36. FRANCIS R, Lewis C
    Myocardial biopsy: techniques and indications.
    Heart. 2018;104:950-958.
    PubMed     Text format    


    May 2018
  37. NG AT, Duan L, Win T, Spencer HT, et al
    Maternal and fetal outcomes in pregnant women with heart failure.
    Heart. 2018 May 25. pii: heartjnl-2018-313156. doi: 10.1136/heartjnl-2018-313156
    PubMed     Text format     Abstract available


  38. NADRUZ W JR, West E, Sengelov M, Grove GL, et al
    Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.
    Heart. 2018 May 15. pii: heartjnl-2018-313234. doi: 10.1136/heartjnl-2018-313234
    PubMed     Text format     Abstract available


    April 2018
  39. APPS A, Lau J, Peterzan M, Neubauer S, et al
    Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging.
    Heart. 2018 Apr 27. pii: heartjnl-2017-312356. doi: 10.1136/heartjnl-2017-312356
    PubMed     Text format     Abstract available


  40. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Text format     Abstract available


  41. ROHDE LE, Beck-da-Silva L
    Alcohol and the heart: the good, the bad and the worse in heart failure.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312924. doi: 10.1136/heartjnl-2017-312924.
    PubMed     Text format    


  42. GUPTA D, Masoud A, Bartoletti S
    The Authors' reply.
    Heart. 2018;104:626.
    PubMed     Text format    


  43. OTTO CM
    Heartbeat: phenotypic heterogeneity of bicuspid aortic valve disease.
    Heart. 2018;104:541-543.
    PubMed     Text format    


    March 2018
  44. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Text format     Abstract available


  45. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910
    PubMed     Text format    


  46. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Text format     Abstract available


  47. NADRUZ W JR, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, et al
    Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Heart. 2018 Mar 9. pii: heartjnl-2017-312869. doi: 10.1136/heartjnl-2017-312869.
    PubMed     Text format     Abstract available


  48. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    


  49. WAGNER F, Gebauer RA, Paech C
    Newborn in cardiogenic shock.
    Heart. 2018;104:467.
    PubMed     Text format     Abstract available


    February 2018
  50. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed     Text format    


  51. WILSON AJ, Gill EK, Abudalo RA, Edgar KS, et al
    Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Heart. 2018;104:293-299.
    PubMed     Text format     Abstract available


    January 2018
  52. WITTE KK, Patel PA, Walker AMN, Schechter CB, et al
    Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.
    Heart. 2018 Jan 31. pii: heartjnl-2017-312539. doi: 10.1136/heartjnl-2017-312539
    PubMed     Text format     Abstract available


  53. SQUIRE I
    Socioeconomic status and outcomes in heart failure with reduced ejection fraction.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312814. doi: 10.1136/heartjnl-2017-312814
    PubMed     Text format    


  54. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Text format     Abstract available


  55. WANG YC, Huang CW, Lin TW
    Acute heart failure with new-onset continuous murmur in a 26-year-old man.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312506. doi: 10.1136/heartjnl-2017-312506
    PubMed     Text format     Abstract available


  56. ZAKERI R, Cowie MR
    Heart failure with preserved ejection fraction: controversies, challenges and future directions.
    Heart. 2018 Jan 5. pii: heartjnl-2016-310790. doi: 10.1136/heartjnl-2016-310790.
    PubMed     Text format     Abstract available


  57. FRAGASSO G
    Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?
    Heart. 2018;104:88-89.
    PubMed     Text format    


  58. NATHANIA M, Hollingsworth KG, Bates M, Eggett C, et al
    Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women.
    Heart. 2018;104:111-118.
    PubMed     Text format     Abstract available


    December 2017
  59. MCMURRAY JJV, Trueman D, Hancock E, Cowie MR, et al
    Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
    Heart. 2017 Dec 21. pii: heartjnl-2016-310661. doi: 10.1136/heartjnl-2016-310661
    PubMed     Text format     Abstract available


  60. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Text format     Abstract available


  61. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Text format     Abstract available


  62. RAO P, Faddis M
    Cardiac resynchronisation therapy: current indications, management and basic troubleshooting.
    Heart. 2017;103:2000-2007.
    PubMed     Text format    


    November 2017
  63. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Text format     Abstract available


  64. MORTON G, Masters J, Cowburn PJ
    Multidisciplinary team approach to heart failure management.
    Heart. 2017 Nov 23. pii: heartjnl-2016-310598. doi: 10.1136/heartjnl-2016-310598
    PubMed     Text format    


  65. HUTCHINGS DC, Anderson SG, Trafford AW
    Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Heart. 2017;103:1745.
    PubMed     Text format    


    October 2017
  66. LEE H, Lee SE, Park CS, Park JJ, et al
    Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction.
    Heart. 2017 Oct 27. pii: heartjnl-2017-312084. doi: 10.1136/heartjnl-2017-312084
    PubMed     Text format     Abstract available


  67. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Heart. 2017 Oct 5. pii: heartjnl-2017-311813. doi: 10.1136/heartjnl-2017-311813.
    PubMed     Text format     Abstract available


  68. BOTTLE A, Kim D, Aylin P, Cowie MR, et al
    Routes to diagnosis of heart failure: observational study using linked data in England.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312183. doi: 10.1136/heartjnl-2017-312183.
    PubMed     Text format     Abstract available


  69. PETRIE MC, Rocchiccioli P
    Coronary angiography in heart failure: when and why? Uncertainty reigns.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312200. doi: 10.1136/heartjnl-2017-312200.
    PubMed     Text format    


  70. SINGH JSS, Burrell LM, Cherif M, Squire IB, et al
    Sacubitril/valsartan: beyond natriuretic peptides.
    Heart. 2017;103:1569-1577.
    PubMed     Text format     Abstract available


  71. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Text format     Abstract available


    August 2017
  72. SCHNELL F, Donal E
    Pharmacological strategies in heart failure with preserved ejection fraction: time for an individualised treatment strategy?
    Heart. 2017 Aug 18. pii: heartjnl-2017-312119. doi: 10.1136/heartjnl-2017-312119
    PubMed     Text format    


  73. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    PubMed     Text format     Abstract available


  74. ZHENG SL, Chan FT, Nabeebaccus AA, Shah AM, et al
    Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311652. doi: 10.1136/heartjnl-2017-311652.
    PubMed     Text format     Abstract available


    July 2017
  75. TUEGEL C, Bansal N
    Heart failure in patients with kidney disease.
    Heart. 2017 Jul 17. pii: heartjnl-2016-310794. doi: 10.1136/heartjnl-2016-310794
    PubMed     Text format     Abstract available


  76. SCHMIDT M
    Interaction between body mass index and physical fitness in primary heart failure prevention.
    Heart. 2017 Jul 17. pii: heartjnl-2017-311504. doi: 10.1136/heartjnl-2017-311504
    PubMed     Text format    


  77. MINAMINO-MUTA E, Kato T, Morimoto T, Taniguchi T, et al
    Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
    Heart. 2017 Jul 6. pii: heartjnl-2016-311022. doi: 10.1136/heartjnl-2016-311022.
    PubMed     Text format     Abstract available


  78. D'AMARIO D, Amodeo A, Adorisio R, Tiziano FD, et al
    A current approach to heart failure in Duchenne muscular dystrophy.
    Heart. 2017 Jul 1. pii: heartjnl-2017-311269. doi: 10.1136/heartjnl-2017-311269.
    PubMed     Text format     Abstract available


  79. GROGAN M, Dispenzieri A, Gertz MA
    Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Heart. 2017;103:1065-1072.
    PubMed     Text format     Abstract available


    June 2017
  80. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed     Text format    


  81. ROHDE LE, Biolo A
    The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure.
    Heart. 2017 Jun 5. pii: heartjnl-2017-311558. doi: 10.1136/heartjnl-2017-311558.
    PubMed     Text format    


    May 2017
  82. CRUMP C, Sundquist J, Winkleby MA, Sundquist K, et al
    Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
    Heart. 2017 May 12. pii: heartjnl-2016-310716. doi: 10.1136/heartjnl-2016-310716
    PubMed     Text format     Abstract available


  83. CARLSON S, Duber HC, Achan J, Ikilezi G, et al
    Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
    Heart. 2017 May 10. pii: heartjnl-2016-310913. doi: 10.1136/heartjnl-2016-310913
    PubMed     Text format     Abstract available


  84. KUTYIFA V
    Gender-specific outcomes of cardiac resynchronisation therapy with or without defibrillator.
    Heart. 2017;103:732-733.
    PubMed     Text format    


  85. OTTO CM
    Heartbeat: Cardiac resynchronization therapy with or without defibrillation: are women different?
    Heart. 2017;103:727-728.
    PubMed     Text format    


    April 2017
  86. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available


    March 2017
  87. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.
    PubMed     Text format    


  88. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.
    PubMed     Text format    


    February 2017
  89. ROSMINI S, Biagini E, O'Mahony C, Bulluck H, et al
    Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Heart. 2017;103:300-306.
    PubMed     Text format     Abstract available


    January 2017
  90. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    PubMed     Text format     Abstract available


    December 2016
  91. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    PubMed     Text format     Abstract available


  92. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    PubMed     Text format     Abstract available


  93. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.
    PubMed     Text format    


  94. BURCHILL LJ
    Heart transplantation in adult congenital heart disease.
    Heart. 2016;102:1871-1877.
    PubMed     Text format     Abstract available


    November 2016
  95. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191
    PubMed     Text format    


    October 2016
  96. CHIMURA M, Onishi T, Tsukishiro Y, Sawada T, et al
    Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Heart. 2016 Oct 31. pii: heartjnl-2016-309746. doi: 10.1136/heartjnl-2016-309746
    PubMed     Text format     Abstract available


  97. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039
    PubMed     Text format    


  98. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536
    PubMed     Text format    


  99. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Text format     Abstract available


  100. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Text format     Abstract available


    September 2016
  101. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336
    PubMed     Text format    


  102. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Text format     Abstract available


  103. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    PubMed     Text format     Abstract available


  104. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    PubMed     Text format     Abstract available


  105. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  106. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    PubMed     Text format     Abstract available


  107. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    PubMed     Text format     Abstract available


    June 2016
  108. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


    February 2016
  109. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.
    PubMed     Text format    


  110. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.
    PubMed     Text format    


    December 2015
  111. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: